What question did this study set out to answer?

To provide updated, evidence-informed clinical recommendations regarding the therapeutic administration of corticosteroids in patients presenting with sepsis, acute respiratory distress syndrome (ARDS), and community-acquired pneumonia (CAP).

January 19, 2024Critical Care MedicineOpen Access

2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia

View Full Paper

Ask AI

Bookmark

To provide updated, evidence-informed clinical recommendations regarding the therapeutic administration of corticosteroids in patients presenting with sepsis, acute respiratory distress syndrome (ARDS), and community-acquired pneumonia (CAP).
A multidisciplinary expert panel conducted a focused review and synthesis of recent clinical trial evidence.
The panel updated consensus recommendations to guide healthcare providers and decision-makers on corticosteroid management in acute critical illness.
Provides revised practice guidance regarding clinical indications, administration timing, and therapeutic roles for corticosteroids in sepsis, ARDS, and CAP.
Synthesizes current trial data qualitatively to balance the therapeutic anti-inflammatory benefits against potential drug-related adverse events in critical care settings.

Implication

Clinical practice guideline reports updated evidence on corticosteroid efficacy in critically ill patients, highlighting refined therapeutic indications across sepsis, ARDS, and pneumonia.

Abstract

The panel provided updated recommendations based on current evidence to inform clinicians, patients, and other stakeholders on the use of corticosteroids for sepsis, ARDS, and CAP.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chaudhuri et al. (2024) studied this question.

synapsesocial.com/papers/69d8fe3bb305d713c2bed8fc https://doi.org/10.1097/ccm.0000000000006172

View Full Paper

Ask AI

Bookmark

Implication

Clinical practice guideline reports updated evidence on corticosteroid efficacy in critically ill patients, highlighting refined therapeutic indications across sepsis, ARDS, and pneumonia.

Abstract

The panel provided updated recommendations based on current evidence to inform clinicians, patients, and other stakeholders on the use of corticosteroids for sepsis, ARDS, and CAP.

2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia

Key Points

Implication

Abstract

Discussion

Cite This Study

2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading